SCHEMBL2691

SCHEMBL2691

CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)OCc1ccccc1)C(C)C

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 13/20 0.61
LTB4R2 Q9NPC1 9/20 0.59
ABCB11 O95342 1/20 0.59
GP6 Q9HCN6 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14193717 1.00 AGTR1 (0.61) AGTR1LTB4R2ABCB11GP6
SCHEMBL2950 1.00 AGTR1 (0.61) AGTR1LTB4R2ABCB11GP6
SCHEMBL683543 0.93 AGTR1 (0.64) AGTR1LTB4R2ABCB11GP6
Acetic Acid SCHEMBL28371506 0.93 AGTR1 (0.62) AGTR1LTB4R2ABCB11GP6
SCHEMBL5949171 0.92 AGTR1 (0.53) AGTR1LTB4R2ABCB11GP6
SCHEMBL5949176 0.92 AGTR1 (0.53) AGTR1LTB4R2ABCB11GP6
SCHEMBL3473866 0.92 AGTR1 (0.50) AGTR1LTB4R2ABCB11GP6
SCHEMBL3473870 0.92 AGTR1 (0.50) AGTR1LTB4R2ABCB11GP6
SCHEMBL29669823 0.91 AGTR1 (0.73) AGTR1LTB4R2ABCB11GP6
SCHEMBL2252 0.91 AGTR1 (0.73) AGTR1LTB4R2ABCB11GP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112641773-A Composition containing heterocyclic compound and use thereof 黄泳华 2021-04-13 CN claimed
CN-111265518-A Composition containing a mixture of biphenyl derivatives and uses thereof 黄泳华 2020-06-12 CN claimed
CN-104844790-B TPGS cholesterol carbonic ester and its preparation method and application 沈阳药科大学 2017-10-03 CN claimed
CN-104163915-B Cholesterol-poloxamer-cholesterol triblock copolymer and its preparation method and application 沈阳药科大学 2016-09-28 CN claimed
CN-104844790-A Tocopheryl polyethylene glycol succinate-cholesterol carbonate, and preparation method and application thereof UNIV SHENYANG PHARMACEUTICAL 2015-08-19 CN claimed
CN-104163915-A Cholesterol-poloxamer-cholesterol triblock copolymer, preparation method and application thereof UNIV SHENYANG PHARMACEUTICAL 2014-11-26 CN claimed
EP-0443983-B1 Acyl compounds CIBA GEIGY AG (CH) 1996-02-28 EP claimed
EP-0443983-A1 Acyl compounds CIBA-GEIGY AG (CH) 1991-08-28 EP claimed
CN-112641773-A Composition containing heterocyclic compound and use thereof 黄泳华 2021-04-13 CN disclosed
CN-111265518-A Composition containing a mixture of biphenyl derivatives and uses thereof 黄泳华 2020-06-12 CN disclosed
CN-104415336-B The composition and its application in pharmaceutical preparation that poloxamer plays phenomenon covered with clouds can be eliminated 沈阳药科大学 2019-05-03 CN disclosed
CN-106075467-B PSA-TPGS conjugate and its application 沈阳药科大学 2019-05-03 CN disclosed
CN-105420338-B A kind of method that lipase fractionation DL- Valsartan ester prepares L- Valsartan 天台宜生生化科技有限公司 2019-02-26 CN disclosed
CN-104844790-B TPGS cholesterol carbonic ester and its preparation method and application 沈阳药科大学 2017-10-03 CN disclosed
WO-2004111018-A1 A NOVEL PROCESS FOR PREPARATION OF VALSARTAN HETERO DRUGS LIMITED (IN) 2004-12-23 WO disclosed
WO-2004111018-A1 A NOVEL PROCESS FOR PREPARATION OF VALSARTAN HETERO DRUGS LIMITED (IN) 2004-12-23 WO disclosed
US-5965592-A HYPOTENSIVE AGENTS NOVARTIS CORPORATION (US) 1999-10-12 US disclosed
EP-0443983-B1 Acyl compounds CIBA GEIGY AG (CH) 1996-02-28 EP disclosed
US-5399578-A Hypotensive; valsartan; high blood pressure and cardiac insufficiency CIBA-GEIGY CORP (US) 1995-03-21 US disclosed
EP-0443983-A1 Acyl compounds CIBA-GEIGY AG (CH) 1991-08-28 EP disclosed